# Allopurinol

## Tonsaric 100mg

| TAH Drug Code      | [OTON](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OTON){:target="_blank"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Reduces urate conc, manifestations of urate/uric acid deposition. Prevention & treatment of Ca oxalate/phosphate renal stones. Manifestations of hyperuricaemia &/or hyperuricosuria.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Dosing             | Adults: Antigout agent: Initial dose:100mg QD, increase by 100 mg/day during one-week intervals until the required serum uric acid concentration is reached. maximum:800mg/day. Maintenance dose:100mg-200mg BID-TID, or 300mg QD. The general maintenance dose for people with mild gout is 200 to 300 mg per day. In moderately severe Tophaceaus gout, the general maintenance dose is 400 to 600 mg per day. Neoplastic disease therapy:12 hours to 3 days (preferably 2 to 3 days) before the start of chemotherapy or radiotherapy, 600 mg to 800 mg per day. Antiurolithic(Uric acid caliculi):100-200mg QD. maximum dose: each dose 300mg, 800mg/day Children: Neoplastic disease therapy:<6 years old:50mg TID 6-12 years old: 100mg TID or 300mg QD. After 48 hours of treatment, adjust the dose according to the patient's condition. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | GI intolerance.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Adverse Effects    | Common: Maculopapular eruption (1% or greater), Rash (1% or greater), Diarrhea (1% or greater), Nausea (1% or greater), Alkaline phosphatase above reference range (1% or greater), ALT/SGPT level raised (1% or greater), Aspartate aminotransferase serum level above reference range (1% or greater), Gout, acute (1% or greater) Serious: Pruritus (< 1%), Stevens-Johnson syndrome (< 1%), Toxic epidermal necrolysis (< 1%), Loss of appetite (< 1%), Weight loss, Agranulocytosis (< 1%), Aplastic anemia (< 1%), Leukopenia (< 1%), Myelosuppression, Thrombocytopenia (< 1%), Granulomatous hepatitis (< 1%), Hepatic necrosis (< 1%), Hepatotoxicity, Drug reaction with eosinophilia and systemic symptoms, Hypersensitivity reaction, Dizziness (< 1%), Somnolence (< 1%), Acute renal failure, Renal failure (< 1%)                  |
| Pregnancy          | No (Limited) Human Data â€“ No Relevant Animal Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| More Info          | [UpToDate](https://www.uptodate.com/contents/allopurinol-drug-information){:target="_blank"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

